Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Model-based predictive closed-loop ICU sedation after coronary artery reconstruction surgery
2007-006217-16Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Nov 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of propofol and remifentanil in None and Coronary artery bypass graft (CABG), sponsored by Ghent University Hospital. Primary endpoint: Propofol and remifentanil dose to maintain BIS in target range. Started Nov 2007; status: completed.
02
Drugs
propofolremifentanil
03
Conditions
Coronary artery bypass graft (CABG)
Beyond the preview
Go deeper on 2007-006217-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006217-16.